companydata.dkNovo Nordisk Research Center Gladsaxe ApS: Financial statements 2018
CVR: 39119374
Novo Nordisk Research Center Gladsaxe ApS (CVR 39119374) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 14,947,235 and a net result of DKK 9,820,500. Equity amounted to DKK 51,515. The company had 1 employee in the financial year.
- Gross Profit
- 14,947,235 kr.
- Profit/Loss
- 9,820,500 kr.
- Equity
- 51,515 kr.
- Employees
- 1
Keep an eye on Novo Nordisk Research Center Gladsaxe ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
On August 15, 2018, the company changed its name from Embark Biotech IvS to Embark Biotech ApS.
About Novo Nordisk Research Center Gladsaxe ApS
Novo Nordisk Research Center Gladsaxe ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Embark Biotech ApS and Embark Biotech IvS. The management consists of Rikke Ryttergaard Andersen. The company is owned by NOVO NORDISK A/S. The company has 7 employees. In 2025, the company reported a gross profit of DKK -1,000 and a net result of DKK 48,000 compared with DKK 6,174,000 the year before. Equity amounted to DKK 807,000.